Osteogenic sarcoma of the extremity with detectable lung metastases at presentation
暂无分享,去创建一个
S. Ferrari | G. Bacci | M. Manfrini | C. Forni | A. Briccoli | M. Mercuri | D. Donati | D Donati | G Bacci | M Mercuri | A Briccoli | S Ferrari | F Bertoni | C Monti | A Zanoni | C Forni | M Manfrini | C. Monti | F. Bertoni | Antonio Zanoni
[1] U. Pastorino,et al. Median sternotomy and multiple lung resections for metastatic sarcomas. , 1990, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[2] M. Usui,et al. [Adjuvant chemotherapy of osteosarcoma]. , 1990, Gan to kagaku ryoho. Cancer & chemotherapy.
[3] D. Saltzman,et al. A new approach to the resection of pulmonary osteosarcoma metastases: results of aggressive metastasectomy. , 1991, La Chirurgia degli organi di movimento.
[4] N. Jaffe,et al. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. , 1974, The New England journal of medicine.
[5] D. Dexter,et al. Human tumor cell heterogeneity and metastasis. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] K. Winkler,et al. Pulmonary metastases from osteogenic sarcoma: Complete resection and effective chemotherapy contributing to improved prognosis , 1985 .
[7] E. Holmes,et al. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] A. Huvos,et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] S. Ferrari,et al. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin , 1993, Cancer.
[10] J. V. van Horn,et al. Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study. , 1986, European journal of cancer & clinical oncology.
[11] G Rosen,et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] W. Meyer,et al. Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis , 1992, Cancer.
[13] G. Rosen,et al. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. , 1979, Cancer.
[14] J. Roth,et al. Survival following aggressive resection of pulmonary metastases from osteogenic sarcoma: analysis of prognostic factors. , 1983, The Annals of thoracic surgery.
[15] J. Shuster,et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. , 1986, The New England journal of medicine.
[16] R. Gelber,et al. Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] N. Jaffe,et al. Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy regional mapping of viable and nonviable tumor , 1985, Cancer.
[18] H. Jürgens,et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] D. Valteau‐Couanet,et al. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] A. Stenwig,et al. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] G. Rosen,et al. Chemotherapy and thoractomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery , 1978, Cancer.
[22] N. Martini,et al. Results of multiple pulmonary resections for metastatic osteogenic sarcoma after two decades , 1991, Journal of surgical oncology.
[23] M. Simon,et al. Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] J. Høie,et al. Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival , 1995, Cancer.